Literature DB >> 11745720

Definition of a solvent system for spherical crystallization of salbutamol sulfate by quasi-emulsion solvent diffusion (QESD) method.

M Nocent1, L Bertocchi, F Espitalier, M Baron, G Couarraze.   

Abstract

In this paper we describe how the spherical crystallization process by QESD method can be applied to a water-soluble drug, salbutamol sulfate. The type of solvent, antisolvent, and emulsifier and the concentration of emulsifier to be used for the production of spherical particles with a size range 80-500 microm are determined. Furthermore, the solvent/antisolvent ratio and the temperature difference between them (Delta T) are studied. It was observed that, in the case of salbutamol sulfate, the Delta T value has no influence on the formation of spherical particles. A very large metastable zone of salbutamol sulfate in water could explain this phenomenon. Finally, the influence of emulsifier concentration and of maturation time on the size of spherical particles is studied. The results show that these two parameters must be fixed to control the size of the recovered particles. Copyright 2001 Wiley-Liss, Inc. and the American Pharmaceutical Association J Pharm Sci 90:1620-1627, 2001

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11745720     DOI: 10.1002/jps.1112

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  7 in total

Review 1.  How spherical crystallization improves direct tableting properties: a review.

Authors:  Maryam Maghsoodi
Journal:  Adv Pharm Bull       Date:  2012-08-15

Review 2.  Role of solvents in improvement of dissolution rate of drugs: crystal habit and crystal agglomeration.

Authors:  Maryam Maghsoodi
Journal:  Adv Pharm Bull       Date:  2015-03-05

3.  Towards a better understanding of the role of stabilizers in QESD crystallizations.

Authors:  Jerome Hansen; Peter Kleinebudde
Journal:  Pharm Res       Date:  2022-03-09       Impact factor: 4.200

4.  Preparation and characterization of microparticles of piroxicam by spray drying and spray chilling methods.

Authors:  M Dixit; A G Kini; P K Kulkarni
Journal:  Res Pharm Sci       Date:  2010-07

5.  Development and optimization of polymeric self-emulsifying nanocapsules for localized drug delivery: design of experiment approach.

Authors:  Jyoti Wadhwa; Abhay Asthana; Sumeet Gupta; Gyati Shilkari Asthana; Ranjit Singh
Journal:  ScientificWorldJournal       Date:  2014-11-24

6.  Development, Optimization and Characterization of Eudraguard®-based Microparticles for Colon Delivery.

Authors:  Claudia Curcio; Antonio S Greco; Salvatore Rizzo; Lorena Saitta; Teresa Musumeci; Barbara Ruozi; Rosario Pignatello
Journal:  Pharmaceuticals (Basel)       Date:  2020-06-24

7.  Increasing the Batch Size of a QESD Crystallization by Using a MSMPR Crystallizer.

Authors:  Jerome Hansen; Peter Kleinebudde
Journal:  Pharmaceutics       Date:  2022-06-09       Impact factor: 6.525

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.